A dual-action implant for bone cancer surgery.
OncoGlass is an early-stage gallium-doped bioactive glass designed to help eliminate residual cancer cells at the surgical site while supporting bone regeneration
Our Process
How OncoGlass Works.
OncoGlass is a resorbable implant designed to eliminate residual cancer cells at the surgical site while supporting bone regeneration.
Placed at the surgical site
Fills the bone defect after tumour removal, supporting repair and local control.
Releases gallium locally
Gradually releases gallium ions at the site, targeting remaining cancer cells.
Supports bone regeneration
Stimulates natural bone healing as the material gradually resorbs over time now.
Our Value
Rethinking bone cancer reconstruction
Local cancer control
Designed to target residual cancer cells at the surgical site.
Supports bone regeneration
Built to stimulate bone healing after tumour removal.
One implant, two functions
Combines local treatment and bone repair in one approach.
Reduced treatment burden
May reduce reliance on additional post-operative therapies.
Works where it is needed
Applied directly at the site of repair and local control.
Designed for complex defects
Intended as a putty or paste for irregular bone defects.
WHO IT’S FOR
Where OncoGlass could be used
OncoGlass is relevant to clinical, research, and commercial stakeholders involved in bone cancer treatment and biomaterials.
Clinicians & Surgeons
Orthopaedic oncologists managing bone tumours who need improved solutions for reconstruction and local tumour control.
Medtech & Pharma
Companies developing bone substitutes or oncology treatments seeking differentiated, early-stage technologies.
Researchers & Academics
Biomaterials and cancer researchers interested in collaboration, pre-clinical studies, and translational research.
Have Your Say!
We’re engaging with clinicians, researchers, and industry stakeholders to better understand the challenges in bone cancer treatment and reconstruction.